Singleton Michael W, Holbert William H, Lee Anh Tuyet, Bracey James M, Churn Severn B
Department of Anatomy and Neurobiology, Virginia Commonwealth University, Richmond, Virginia 23298-0599, USA.
Epilepsia. 2005 Sep;46(9):1389-400. doi: 10.1111/j.1528-1167.2005.19205.x.
This study was conducted to characterize the early cellular changes in CaM kinase II activity that occur during the induction of status epilepticus (SE).
The pilocarpine model of SE was characterized both behaviorally and electrographically. At specific time points after the first discrete seizure, specific brain regions were isolated for biochemical study. Phosphate incorporation into a CaM kinase II-specific substrate, autocamtide III, was used to determine kinase activity.
After the development of SE, the data show an immediate inhibition of both cortical and hippocampal CaM kinase II activity in homogenate, but a delayed inhibition in synaptic kinase activity. The maintenance of synaptic kinase activity was due to a translocation of CaM kinase II protein to the synapse. However, despite the translocation of functional kinase, CaM kinase II activity was not maintained, membrane potential was not restored, and the newly translocated CaM kinase II did not terminate the SE event. Unlike the homogenate samples, in the crude synaptoplasmic membrane (SPM) subcellular fractions, a positive correlation is found between the duration of SE and the inhibition of CaM kinase II activity in both the cortex and hippocampus.
The data support the hypothesis that alterations of CaM kinase II activity are involved in the early events of SE pathology.
本研究旨在描述癫痫持续状态(SE)诱导过程中钙调蛋白激酶II(CaM kinase II)活性早期细胞变化的特征。
通过行为学和脑电图对毛果芸香碱诱导的SE模型进行特征描述。在首次离散发作后的特定时间点,分离特定脑区进行生化研究。采用将磷酸掺入CaM kinase II特异性底物自磷酸化钙调蛋白III(autocamtide III)的方法来测定激酶活性。
SE发作后,数据显示匀浆中皮质和海马的CaM kinase II活性立即受到抑制,但突触激酶活性的抑制出现延迟。突触激酶活性的维持归因于CaM kinase II蛋白向突触的转位。然而,尽管功能性激酶发生了转位,但CaM kinase II活性并未维持,膜电位未恢复,新转位的CaM kinase II也未终止SE发作。与匀浆样本不同,在粗制突触质膜(SPM)亚细胞组分中,发现皮质和海马中SE持续时间与CaM kinase II活性抑制之间呈正相关。
数据支持以下假设,即CaM kinase II活性改变参与了SE病理的早期事件。